We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
14 hedge funds and large institutions have $3.26M invested in Plus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
61% more capital invested
Capital invested by funds: $2.03M → $3.26M (+$1.23M)
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
7% less funds holding
Funds holding: 15 → 14 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.55M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$145K |
| 3 |
Morgan Stanley
New York
|
+$120K |
| 4 |
OCA
Otter Creek Advisors
Palm Beach Gardens,
Florida
|
+$85.2K |
| 5 |
BlackRock
New York
|
+$17.9K |
Top Sellers
| 1 |
Two Sigma Advisers
New York
|
-$188K |
| 2 |
Renaissance Technologies
New York
|
-$141K |
| 3 |
Two Sigma Investments
New York
|
-$104K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$87K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$27K |
